This brand name is authorized in Nigeria.
The drug MOLOXIDEX contains a combination of these active pharmaceutical ingredients (APIs):
1
|
UNII
C53598599T - MOXIFLOXACIN HYDROCHLORIDE
|
|
Moxifloxacin, a fourth-generation fluoroquinolone, has in vitro activity against a wide range of Gram-positive and Gram-negative pathogens. The bactericidal action of moxifloxacin results from the inhibition of both type II topoisomerases (DNA gyrase and topoisomerase IV) required for bacterial DNA replication, transcription and repair. |
|
2
|
UNII
AI9376Y64P - DEXAMETHASONE SODIUM PHOSPHATE
|
|
Dexamethasone is a synthetic glucocorticoid; it combines high anti-inflammatory effects with low mineralocorticoid activity. It has an approximately 7 times greater anti-inflammatory potency than prednisolone, another commonly prescribed corticosteroid. At high doses it reduces the immune response. |
|
3
|
UNII
F5UM2KM3W7 - BENZALKONIUM CHLORIDE
|
This drug has been approved in Nigeria as follows:
| Identifier | Form | Presentation | Description | Approval |
|---|---|---|---|---|
| A4-8999 | Eye drops | MOLOXIDEX EYE DROPS SOL_DROPS 0.1%; 0.5% 1 X 5ml | MOLOXIDEX EYE DROPS MOXIFLOXACIN+DEXAMETHASONE Moxifloxacin 0.5%w/v and Dexamethasone 0.1%w/v. Excipients: Borax, Boric Acid, Sodium Chloride, Hydroxypropyl Betacyclodextrin, Benalkonium Chloride Solution A4-8999 Drugs Imported Products 1 X 5ml Prescription Only Medicine (POM) 19/04/2022 SKT HEALTHCARE PHARMACEUTICALS LTD, OGUNLOWO ST OFF AWOLOWO WAY IKEJA IKEJA LAGOS 14534862 info@sktpharma.com NITIN LIFESCIENCES LIMITED, RAMPUR GHAT ROAD, PAONTA SAHIB,DISTRICT-SIRMOUR (H.P.)- 173 025, INDIA, India | 31/08/2023 |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| S01CA01 | Dexamethasone and antiinfectives | S Sensory organs → S01 Ophthalmologicals → S01C Antiinflammatory agents and antiinfectives in combination → S01CA Corticosteroids and antiinfectives in combination |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| NG | Registered Drug Product Database | A4-8999 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.